USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/30049
Title: Malignancies in children with immunodeficiencies
Authors: Johnson, Jisma
Dolapciu, Elena
Keywords: primary immunodeficiency;malignancy;tumor predisposition
Issue Date: 2024
Publisher: Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova
Citation: JOHNSON, Jisma; DOLAPCIU, Elena. Malignancies in children with immunodeficiencies. In: Revista de Ştiinţe ale Sănătăţii din Moldova = Moldovan Journal of Health Sciences. 2024, vol. 11, nr. 3, anexa 2, p. 668. ISSN 2345-1467.
Abstract: Background. Primary immunodeficiency disorders (PIDs) are a heterogeneous group of genetic conditions characterized by impaired immune function. Recent studies have highlighted a complex connection between PIDs and an increased risk of malignancies. However, the underlying mechanisms remain poorly understood. Objective of the study. This study aims to understand the relationship between immunodeficiency and susceptibility to malignancy by reviewing literature sources. Material and methods. Data from online databases such as Pubmed, UpToDate, and the National Library of Medicine were used to review the literature examining factors associated with malignancy in patients with PID. Results. Cancer is the second most common cause of death in PID patients. The cancer risk in PID patients is estimated to be 4 - 25%, and some studies have reported a notable increase in standardized incidence ratios of various cancers. Non-Hodgkin lymphoma (48%) and Hodgkin lymphoma (10% of cases) are the most common cancers in PIDs, diagnosed often at younger ages. PID-related malignancies affect mainly ataxia-telangiectasia and common variable immunodeficiency patients over 50% of cases, another 30% linked to Wiskott-Aldrich syndrome, severe combined immunodeficiency and selective IgA deficiency. Conclusions. PID patients have a higher risk of many diverse cancers for genetic, immunological, and environmental reasons. Management is challenging, requiring continued surveillance and individualized treatment based on the underlying immunodeficiency and associated complications.
metadata.dc.relation.ispartof: Revista de Științe ale Sănătății din Moldova = Moldovan Journal of Health Sciences
URI: https://cercetare.usmf.md/sites/default/files/inline-files/MJHS_11_3_2024_anexa2__site.pdf
http://repository.usmf.md/handle/20.500.12710/30049
ISSN: 2345-1467
Appears in Collections:Revista de Științe ale Sănătății din Moldova : Moldovan Journal of Health Sciences 2024 Vol. 11, Issue 2

Files in This Item:
File Description SizeFormat 
MALIGNANCIES_IN_CHILDREN_WITH_IMMUNODEFICIENCIES.pdf137.42 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback